+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

E

Actively Recruiting

Malnutrition and anemia often affect adults with chronic kidney disease CKD who undergo regular hemodialysis, potentially worsening their health and quality of life. Researchers are evaluating whether providing a 7.2% amino acid solution KIDMIN through intradialytic parenteral nutrition IDPN during dialysis improves nutritional status in these patients. This retrospective observational study uses existing medical records from Bangli Medika Canti Hospital, Indonesia, covering July 2023 to December 2024. The study compares two groups of adults receiving maintenance hemodialysis those who were given the amino acid-only IDPN during dialysis sessions for at least three months and those who did not receive IDPN but followed the standard CKD diet. IDPN is administered starting 1 to 1.5 hours before the end of each dialysis session, using a 200 mL KIDMIN injection. No additional treatments or invasive procedures are involved, as the study relies on previously collected clinical data. Participants nutritional status is evaluated by measuring changes in serum albumin levels from baseline to three months, along with follow-up assessments through six months. Other measures include hemoglobin levels, nutritional assessments using the Subjective Global Assessment tool, and quality of life evaluated by the Kidney Disease Quality of Life questionnaire. All data are collected from routine clinical care records, ensuring patient confidentiality through data de-identification.

Age: 18Years +All Genders
1 location